1d
Medpage Today on MSNWhat's the Better Option for High-Risk Prostate Cancer -- Radiation or Surgery?SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...
The decision comes just a few months after Bayer reported encouraging results for eliapixant in chronic cough – the same indication sought by Merck for gefapixant – saying it hit its objective ...
If We Build It, Why They Do Not Come? An American College of Surgeons National Quality Improvement Collaborative to Understand Barriers to Completion of Cancer Treatment This retrospective study used ...
(Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by ...
Novartis has agreed to buy Anthos Therapeutics from private equity firm Blackstone for $3.1 billion, adding a drug in ...
1d
24/7 Wall St. on MSNBuy the Biggest S&P 500 Losers: 5 High-Yield Dividend Companies Are On SaleThese S&P 500 stocks with dependable dividends and Buy ratings look like incredible contrarian ideas for growth and income ...
The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The ...
Certain hormonal contraceptives are associated with a higher stroke and heart attack risk, finds a large study from Denmark in The BMJ today that draws on prescription records to give more precise ...
Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...
Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.
1d
Hosted on MSNTalazoparib-Enzalutamide Improves Survival in Metastatic CRPCAdding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results